Organization
D. Western Therapeutics Institute
1 clinical trial
Clinical trial
A Phase 2b Randomized, Double-masked, Active-controlled, Dose-response Study of the Safety and Efficacy of H-1337 in Subjects With Primary Open Angle Glaucoma (POAG) or Ocular HypertensionStatus: Recruiting, Estimated PCD: 2025-12-01